279 related articles for article (PubMed ID: 22956574)
1. Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.
Mathew J; Katz R; St John Sutton M; Dixit S; Gerstenfeld EP; Ghio S; Gold MR; Linde C; Shlipak MG; Deo R
Eur J Heart Fail; 2012 Dec; 14(12):1420-8. PubMed ID: 22956574
[TBL] [Abstract][Full Text] [Related]
2. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
[TBL] [Abstract][Full Text] [Related]
6. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
[TBL] [Abstract][Full Text] [Related]
7. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
[TBL] [Abstract][Full Text] [Related]
8. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
[TBL] [Abstract][Full Text] [Related]
9. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
10. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
[TBL] [Abstract][Full Text] [Related]
11. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
[TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
[TBL] [Abstract][Full Text] [Related]
13. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
[TBL] [Abstract][Full Text] [Related]
14. The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy.
Kristiansen HM; Vollan G; Hovstad T; Keilegavlen H; Faerestrand S
Eur Heart J Cardiovasc Imaging; 2012 Dec; 13(12):991-1000. PubMed ID: 22677455
[TBL] [Abstract][Full Text] [Related]
15. Relationship between two-dimensional speckle-tracking septal strain and response to cardiac resynchronization therapy in patients with left ventricular dysfunction and left bundle branch block: a prospective pilot study.
Maréchaux S; Guiot A; Castel AL; Guyomar Y; Semichon M; Delelis F; Heuls S; Ennezat PV; Graux P; Tribouilloy C
J Am Soc Echocardiogr; 2014 May; 27(5):501-11. PubMed ID: 24513239
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold M; Abraham WT; Daubert JC;
Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
[TBL] [Abstract][Full Text] [Related]
17. Tricuspid annular plane systolic excursion and response to cardiac resynchronization therapy: results from the REVERSE trial.
Kjaergaard J; Ghio S; St John Sutton M; Hassager C
J Card Fail; 2011 Feb; 17(2):100-7. PubMed ID: 21300298
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
Wang CL; Powell BD; Redfield MM; Miyazaki C; Fine NM; Olson LJ; Cha YM; Espinosa RE; Hayes DL; Hodge DO; Lin G; Friedman PA; Oh JK
Eur J Heart Fail; 2012 May; 14(5):517-25. PubMed ID: 22411692
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular remodelling and change in left ventricular global longitudinal strain after cardiac resynchronization therapy: prognostic implications.
van der Bijl P; Kostyukevich MV; Khidir M; Ajmone Marsan N; Delgado V; Bax JJ
Eur Heart J Cardiovasc Imaging; 2019 Oct; 20(10):1112-1119. PubMed ID: 31329827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
